跳至主要内容
临床试验/NCT01375335
NCT01375335暂停4 期

The Effects of Dobutamine on Postoperative Systolic Deformation and Diastolic Function in Patients With Hypertrophic Cardiomyopathy Operated for Aortic Valve Stenosis

University of Aarhus1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2011年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
暂停
入组人数
10
试验地点
1
主要终点
Cardiac output

研究概览

简要总结

The use of dobutamine in postoperative hemodynamic treatment is widespread despite seemingly intact contraction of the heart. This study aims to elucidate the efficacy of low-dose dobutamine infusion in patients in the postoperative phase replacement of the aortic valve.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-90 years
  • Left ventricular posterior wall =/>12mm
  • Ejection fraction > 45%
  • Sinus rhythm
  • Eligible for aortic valve replacement

排除标准

  • Need for concomitant cardiac bypass operation.
  • Moderate or severe insufficiency of the mitral valve
  • Active endocarditis
  • Insufficient ultrasound window
  • Using B-blockers
  • Liver insufficiency
  • Patients treated with COMT-inhibitors
  • Allergy towards dobutamine
  • Pregnancy
  • Women of fertile age who do not use relevant anti-conception
  • Lacking participant consent

研究组 & 干预措施

Dobutamine

Experimental

干预措施: Dobutamine (Drug)

结局指标

主要结局

Cardiac output

时间窗: From 0 to 90 minutes after drug initiation

Change in cardiac output (l/min) from initiation of study drug or placebo until 90 minutes of infusion.

次要结局

  • Mean pulmonary artery pressure(From 0 to 90 minutes after drug initiation.)
  • Echocardiography(From 0 minutes to 90 minutes after drug initiation)
  • Changes in mixed venous saturation(From 0 minutes to 90 minutes after drug initiation)
  • norepinephrine requirement(From 0 minutes to 90 minutes after drug initiation)
  • Central venous pressure(From 0 minutes to 90 minutes after drug initiation)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验